Alginate-chitosan PEC scaffolds: A useful tool for soft tissues cell therapy.
Alginates
/ administration & dosage
Animals
Biocompatible Materials
/ administration & dosage
Cell Proliferation
Cell Survival
Cells, Cultured
Chitosan
/ administration & dosage
Combined Modality Therapy
/ methods
Disease Models, Animal
Feasibility Studies
Female
Humans
Ischemia
/ therapy
Male
Materials Testing
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells
Polyelectrolytes
/ administration & dosage
Porosity
Primary Cell Culture
Rats
Rats, Inbred Lew
Tissue Engineering
Tissue Scaffolds
/ chemistry
Alginate
Angiogenesis
Biocompatibility
Cell therapy
Chitosan
Mesenchymal stem cells
Polyelectrolyte complex
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Nov 2019
25 Nov 2019
Historique:
received:
31
03
2019
revised:
13
08
2019
accepted:
09
09
2019
pubmed:
15
9
2019
medline:
28
3
2020
entrez:
15
9
2019
Statut:
ppublish
Résumé
In this study we evaluate macroporous scaffolds made of alginate-chitosan polyelectrolyte complexes (PEC) as tools to optimize the results of soft tissues cell therapy. Cell therapy using mesenchymal stem cells (MSC) has become attractive for tissue repair and regeneration in a number of acute and chronic injuries. Unfortunately their low retention and/or survival after injection limit their beneficial effects. A biomaterial-assisted implantation, providing cells a three-dimensional (3D) microenvironment is a promising strategy. To this purpose, we designed a family of PEC scaffolds, and studied if they could meet the requirement of such application. Xray tomography showed that all PEC scaffolds present an interconnected macroporosity, and both rheology and tensile measurements reveal optimized mechanical properties (higher storage moduli and Young moduli) compared to alginate reference scaffolds. In vitro assays demonstrated their ability to allow MSC retention (higher than 90%), long-term viability and FGF2 secretion. Then, we used a skeletal muscle implantation model to assess the biological response to scaffolds graft, and showed that they support in vivo vascular formation within the implant-derived tissue. The combination of alginate/chitosan PEC scaffolds architecture and angiogenic potential make them appear as interesting tools to optimize MSC therapy results in soft tissues.
Identifiants
pubmed: 31520678
pii: S0378-5173(19)30737-9
doi: 10.1016/j.ijpharm.2019.118692
pii:
doi:
Substances chimiques
Alginates
0
Biocompatible Materials
0
Polyelectrolytes
0
Chitosan
9012-76-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118692Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.